new post
StocksRunner logo
mail
search
 
menu
 
Beam Therapeutics In
$28.34
+5.59%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

BEAM Stock Analysis & IQ Rating | Beam Therapeutics In

 
 
 

BEAM

 

Beam Therapeutics In

$28.34

 
+$1.50 | +5.59%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$35.25
 
 
MKT CAP
$2.88B
 
52W Low
$13.53
 
 
VOL
$2.06M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.69M
 
RSI
59.72
 
 
TREND
Uptrend
 
 
 

BQ Stock IQ

 
lock  Login to see Beam Therapeutics In (BEAM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

BEAM Target Price

 
 
 

Strengths

 
 

BEAM Rewards

 Upgraded on attractively valued

BEAM Rewards

 Trading below its fair value

BEAM Rewards

 Earnings are forecast to grow

BEAM Rewards

 Investors confidence is positive

 
 

BEAM Price Performance

 
 

$26.48   (+7.02%)

$26.32   (+7.67%)

$17.63   (+60.75%)

$26.29   (+7.80%)

 
 
1year
6month
3month
1month
 

BEAM Risk Level

 
 

BEAM has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 Beta greater than 1.0

 High volatilty

 
 
BEAM Risk Level
Extreme
LOW
HIGH
 

BEAM Analysts Opinion

 

BEAM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

BEAM Earnings Sentiment

 Earnings decline YoY

BEAM Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

BEAM Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

BEAM Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

 

BEAM Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

BEAM Future Sentiment

 Trading below its fair value

BEAM Future Sentiment

 Earnings are forecast to grow

 
 

BEAM Analysts Opinion

BEAM Analysts opinion is negative and it remained unchanged from the past 3 months

 

BEAM Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
100%
 

BEAM Street Sentiment 

BEAM Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

BEAM Performance Sentiment

 
Sentiments overview associated with BEAM events and the stock performance.
 
 
100%
0%
Positive
Negative
12 out of 12
events present
0 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$28.34
 
Resistance
Price
 
$23.62
 
 
Current Price Range
 
$28.34
 
 
Show methods +
 
 
Linked to BEAM
IQ
Close Price
Change
 

CRSP

4.09

58.19

+5.50%

 
 
 
BEAM Latest Analysis +
 
 
FAQ About BEAM Stock Insights
 

What is BEAM current stock price?

What are BEAM stock strengths?

What is BEAM Risk Level?

What is BEAM market cap and volume?

What is BEAM current Stock IQ?

Should I buy BEAM stock right now?

Is BEAM a Strong Buy right now?

What does a 'Strong Buy' rating mean for BEAM?

What does a 'Strong Sell' rating mean for BEAM?

What factors influence BEAM's Stock IQ?

 
 
StocksRunner

Explore our BEAM Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored BEAM Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BEAM Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

BEAM

 

Beam Therapeutics In

 
 

Current Price

 

$28.34

 
+$1.50 | +5.59%
 
 
52W High
$35.25
 
 
MKT CAP
$2.88B
 
52W Low
$13.53
 
 
VOL
$2.06M
 
P/E Ratio
N/A
 
 
AVG VOL
$1.69M
 
RSI
59.72
 
 
TREND
Uptrend
 
 
 
Set Alerts
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

BEAM Rewards

 Upgraded on attractively valued

BEAM Rewards

 Trading below its fair value

BEAM Rewards

 Earnings are forecast to grow

BEAM Rewards

 Investors confidence is positive

 
 
 

Linked to BEAM

 
 
 
Symbol
IQ
Close
Change
 

CRSP

4.09

58.19

+5.50%

 
 
 
 
 
user
 
 
 
 

BEAM Price Performance

 
 

$26.48   (+7.02%)

$26.32   (+7.67%)

$17.63   (+60.75%)

$26.29   (+7.80%)

 
 
1year
6month
3month
1month
 

BEAM Analysts Opinion

 

BEAM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

BEAM Earnings Sentiment

 Earnings decline YoY

BEAM Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

BEAM Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

BEAM Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

 

BEAM Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

BEAM Future Sentiment

 Trading below its fair value

BEAM Future Sentiment

 Earnings are forecast to grow

 
 

BEAM Analysts Opinion

BEAM Analysts opinion is negative and it remained unchanged from the past 3 months

 

BEAM Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
NA
100%
 

BEAM Street Sentiment 

BEAM Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

BEAM Risk Level

 
 

BEAM has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 

Risks Indicators

 

 Beta greater than 1.0

 High volatilty

 
 
BEAM Risk Level
Extreme
LOW
HIGH
 
BEAM Performance Sentiment
 
Sentiments overview associated with BEAM events and the stock performance.
 
 
100%
0%
Positive
Negative
12 out of 12
events present
0 out of 12
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$28.34
 
Resistance
Price
 
$23.62
 
 
Current Price Range
 
$28.34
 
 
Show methods +
 
 
 
 
 
 

BEAM Stock IQ

 
 
 
lock  Login to unlock Beam Therapeutics In (BEAM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

BEAM Latest Analysis

 
 
 

Can BEAMs Gene Editing Pipeline Create Long-Term Value Amid Rivalry?. Beam Therapeutics advances base-editing pipeline with risto-cel studies and FDA designations but no approved products and rising competition loom.

 

Wed Dec 31, 2025

$27.72 | -0.36%
 
Activity
Potential

Beam Therapeutics Inc. (BEAM) Reports Updated Data From BEACON Phase 1/2 trial Of Ristoglogene. Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2 2025 that Beam Therapeutics Inc. (NASDAQ:BEAM) has released revised safety and effectiveness information from its BEACON Phase 1/2 clinical trial evaluating ristoglogene autogetemcel (previously BEAM-101). It is an investigational genetically engineered ex vivo base editing cell [̷

 

Wed Dec 31, 2025

$27.72 | -0.36%
 
Activity

Do You Think Beam Therapeutics (BEAM) is an Undervalued Stock?.

 

Tue Dec 30, 2025

$27.82 | -0.07%
 
Potential

BEACON Trial Data Makes Beam Therapeutics (BEAM) an Attractive Buy. Beam Therapeutics (NASDAQ:BEAM) is one of the most promising mid-cap healthcare stocks under $50. On December 9 H.C. Wainwright analyst Patrick Trucchio reaffirmed his ish stance on Beam Therapeutics (NASDAQ:BEAM). He rated the stock Buy with a target price of $80 implying a substantial 201% upside. Trucchios rating and huge upside forecasts are based on [….]

 

Mon Dec 22, 2025

$27.92 | +5.08%
 
Activity
Potential
Potential

Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference. CAMBRIDGE Mass. Dec. 18 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BEAM) a biotechnology company developing precision genetic medicines through base editing today announced that John Evans chief executive officer of Beam will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday January 13 2026 at 5:15 p.m. PT in San Francisco.

 

Thu Dec 18, 2025

$26.17 | +2.23%
 
Activity
 
 
 
 
 
StocksRunner

Discover BEAM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of BEAM. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BEAM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BEAM Stock trends

BEAM Stock performance

BEAM Stock analysis

BEAM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

BEAM Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BEAM

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing BEAM

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.